Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Hims & Hers Health ( (HIMS) ) has provided an update.
Hims & Hers Health, Inc. has expanded its board of directors, appointing Deb Autor as the tenth member. She will serve until the 2025 annual meeting and is deemed independent under NYSE standards. Autor will also provide consulting services for a year, earning a $100,000 fee. Her appointment includes joining the Risk Committee alongside other notable directors.
See more data about HIMS stock on TipRanks’ Stock Analysis page.
